DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is now frequently used in early clinical trial assessment of antiangiogenic and vascular disrupting compounds. Evidence of drug efficacy and dose-dependent response has been demonstrated with some angiogenesis inhibitors. This review hig...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Connor, J P B, Jackson, A, Parker, G J M, Jayson, G C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359994/
https://www.ncbi.nlm.nih.gov/pubmed/17211479
http://dx.doi.org/10.1038/sj.bjc.6603515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359994/
https://www.ncbi.nlm.nih.gov/pubmed/17211479
http://dx.doi.org/10.1038/sj.bjc.6603515

Ejemplares similares